| Symbol | TXTM |
|---|---|
| Name | PROTEXT MOBILITY, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 33301 United States FL One West Las Olas Blvd Ste 500 |
| Telephone | +27728892581 |
| Fax | — |
| — | |
| Website | http://www.protxtm.com |
| Incorporation | US |
| Incorporated On | 2001 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Kral Ussery, LLC/Michael Ussery, CPA; |
| Audit Status | UNAUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0001163573 |
| Description | Protext is a Biotech Company developing a Hemp/CBD -- Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Through its wholly owned subsidiary RSAMMD Acquisitions LLC ("RSAMMDA") and under the leadership of its founders Mr. Dylon Du Plooy and Dr. Ahmed Jamaloodeen we partner with leading hospitals and universities globally to advance the clinical benefits and applications of cannabis. Mr. Du Plooy is a South African pioneer in the research and cultivation. Dr. J operates a 5000-hectare farm in New Castle, South Africa and holds hemp permit issued by the Government of South Africa, Department of Agriculture. Together the RSAMMDA founders have been at the forefront of medical cannabis legislation and South African cannabis legalization, which took place in September 2018. The company is committed to the advancement of technology and scientific research that leads to an improved quality of life for patients around the world. Additional info from OTC: |
Protext Mobility Inc. (OTCID: TXTM) Unveils New Corporate Website and Investor Relations Platform to Support Strategic Growth and Exchange Uplisting
Read moreProText Mobility Inc. (OTC: TXTM) Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases
Read more